SG Americas Securities
XLRN

SG Americas Securities’s Acceleron Pharma XLRN Stock Holding History

SG Americas Securities’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,700
Closed -$35K – 3928
2020
Q1 		$35K Buy
+16,700
New +$1.3M ﹤0.01% 3233

SG Americas Securities's XLRN Position: Q4 2021 in Review

SG Americas Securities sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 10,909 shares — an estimated $1.88M sold.

SG Americas Securities first reported a position in XLRN in Q1 2014 and held it in 23 quarters. The position peaked at $4.71M in Q1 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • SG Americas Securities reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 10,909 Acceleron Pharma shares in Q4 2021, an estimated $1.88M.
  • SG Americas Securities first reported a position in Acceleron Pharma in Q1 2014 and held it in 23 quarters.
  • SG Americas Securities's Acceleron Pharma position peaked at $4.71M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.